Taisho Pharmaceutical Holdings Co Ltd - Company Profile
Powered by 
All the data and insights you need on Taisho Pharmaceutical Holdings Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Taisho Pharmaceutical Holdings Co Ltd Strategy Report
- Understand Taisho Pharmaceutical Holdings Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Taisho Pharmaceutical Holdings Co Ltd (Taisho Pharmaceutical) develops and manufactures self-medication drugs and prescription pharmaceuticals for use in therapy areas such as infectious diseases, orthopedic disorders, central nervous system (CNS) diseases and metabolic diseases.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
R&D efforts focus on developing OTC drugs and prescription pharmaceutical products in the therapeutic areas of infectious diseases, orthopedic disorders, central nervous system and metabolic diseases. It also focusses on developing new concept products in the field of lifestyle diseases, which includes health foods. Major pipeline products include TS-152 (injection) has newly filed application for articular rheumatism, TS-071 (Phase III) for Type2 diabetes, TS-142 (Phase II) for insomnia, TS-121 (Phase II) for depression, TS-161 (Phase II) for depression, and TS-134 (Phase I) for schizophrenia. In FY2023, the company incurred expense of JPY20,727 million on its R&D operations, which as a percentage of revenue, stood at 7.0%.
Business Segments
Overview
Focuses on the development of pharmaceutical products for the treatment of metabolic diseases, infectious diseases, orthopedic disorders, and CNS diseases.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Focuses on the development of OTC drugs, supplements, food products, health foods, beauty care products, health information, and health equipment’s. Major products include Lipovitan series of energy drinks, the Pabron series of cold remedies and sinus treatment products, the RiUP series of hair regrowth products and the Colac series of laxative products, the Counterpain series of topical analgesics, the Tempra series of non-narcotic analgesics, the Hapacol series of antipyretic analgesics, the Dafalgan series of antipyretic analgesics, and the Efferalgan series of antipyretic analgesics.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer